Compile Data Set for Download or QSAR
maximum 50k data
Found 17 of ph data with Target = 'Carboxypeptidase B'
TargetCarboxypeptidase B(Homo sapiens (Human))
Sanofi-Aventis Deutschland

US Patent
LigandPNGBDBM120796(US8710232, 33)
Affinity DataIC50:  3nMpH: 7.4 T: 2°CAssay Description:The prepared substances were tested for TAFIa inhibition using the Actichrome plasma TAFI activity kit from American Diagnostica (Pr. No. 874). This ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCarboxypeptidase B(Homo sapiens (Human))
Sanofi-Aventis Deutschland

US Patent
LigandPNGBDBM120790(US8710232, 17)
Affinity DataIC50:  11nMpH: 7.4 T: 2°CAssay Description:The prepared substances were tested for TAFIa inhibition using the Actichrome plasma TAFI activity kit from American Diagnostica (Pr. No. 874). This ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCarboxypeptidase B(Homo sapiens (Human))
Sanofi-Aventis Deutschland

US Patent
LigandPNGBDBM120788(US8710232, 15)
Affinity DataIC50:  12nMpH: 7.4 T: 2°CAssay Description:The prepared substances were tested for TAFIa inhibition using the Actichrome plasma TAFI activity kit from American Diagnostica (Pr. No. 874). This ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCarboxypeptidase B(Homo sapiens (Human))
Sanofi-Aventis Deutschland

US Patent
LigandPNGBDBM120787(US8710232, 13)
Affinity DataIC50:  12nMpH: 7.4 T: 2°CAssay Description:The prepared substances were tested for TAFIa inhibition using the Actichrome plasma TAFI activity kit from American Diagnostica (Pr. No. 874). This ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCarboxypeptidase B(Homo sapiens (Human))
Sanofi-Aventis Deutschland

US Patent
LigandPNGBDBM120786(US8710232, 12)
Affinity DataIC50:  15nMpH: 7.4 T: 2°CAssay Description:The prepared substances were tested for TAFIa inhibition using the Actichrome plasma TAFI activity kit from American Diagnostica (Pr. No. 874). This ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCarboxypeptidase B(Homo sapiens (Human))
Sanofi-Aventis Deutschland

US Patent
LigandPNGBDBM120782(US8710232, 7)
Affinity DataIC50:  16nMpH: 7.4 T: 2°CAssay Description:The prepared substances were tested for TAFIa inhibition using the Actichrome plasma TAFI activity kit from American Diagnostica (Pr. No. 874). This ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCarboxypeptidase B(Homo sapiens (Human))
Sanofi-Aventis Deutschland

US Patent
LigandPNGBDBM120791(US8710232, 18)
Affinity DataIC50:  21nMpH: 7.4 T: 2°CAssay Description:The prepared substances were tested for TAFIa inhibition using the Actichrome plasma TAFI activity kit from American Diagnostica (Pr. No. 874). This ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCarboxypeptidase B(Homo sapiens (Human))
Sanofi-Aventis Deutschland

US Patent
LigandPNGBDBM120785(US8710232, 10)
Affinity DataIC50:  23nMpH: 7.4 T: 2°CAssay Description:The prepared substances were tested for TAFIa inhibition using the Actichrome plasma TAFI activity kit from American Diagnostica (Pr. No. 874). This ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCarboxypeptidase B(Homo sapiens (Human))
Sanofi-Aventis Deutschland

US Patent
LigandPNGBDBM120781(US8710232, 1)
Affinity DataIC50:  30nMpH: 7.4 T: 2°CAssay Description:The prepared substances were tested for TAFIa inhibition using the Actichrome plasma TAFI activity kit from American Diagnostica (Pr. No. 874). This ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCarboxypeptidase B(Homo sapiens (Human))
Sanofi-Aventis Deutschland

US Patent
LigandPNGBDBM120789(US8710232, 16)
Affinity DataIC50:  38nMpH: 7.4 T: 2°CAssay Description:The prepared substances were tested for TAFIa inhibition using the Actichrome plasma TAFI activity kit from American Diagnostica (Pr. No. 874). This ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCarboxypeptidase B(Homo sapiens (Human))
Sanofi-Aventis Deutschland

US Patent
LigandPNGBDBM120797(US8710232, 37)
Affinity DataIC50:  49nMpH: 7.4 T: 2°CAssay Description:The prepared substances were tested for TAFIa inhibition using the Actichrome plasma TAFI activity kit from American Diagnostica (Pr. No. 874). This ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCarboxypeptidase B(Homo sapiens (Human))
Sanofi-Aventis Deutschland

US Patent
LigandPNGBDBM120784(US8710232, 9)
Affinity DataIC50:  439nMpH: 7.4 T: 2°CAssay Description:The prepared substances were tested for TAFIa inhibition using the Actichrome plasma TAFI activity kit from American Diagnostica (Pr. No. 874). This ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCarboxypeptidase B(Homo sapiens (Human))
Sanofi-Aventis Deutschland

US Patent
LigandPNGBDBM120795(US8710232, 31)
Affinity DataIC50:  870nMpH: 7.4 T: 2°CAssay Description:The prepared substances were tested for TAFIa inhibition using the Actichrome plasma TAFI activity kit from American Diagnostica (Pr. No. 874). This ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCarboxypeptidase B(Homo sapiens (Human))
Sanofi-Aventis Deutschland

US Patent
LigandPNGBDBM120793(US8710232, 27)
Affinity DataIC50:  1.11E+3nMpH: 7.4 T: 2°CAssay Description:The prepared substances were tested for TAFIa inhibition using the Actichrome plasma TAFI activity kit from American Diagnostica (Pr. No. 874). This ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCarboxypeptidase B(Homo sapiens (Human))
Sanofi-Aventis Deutschland

US Patent
LigandPNGBDBM120783(US8710232, 8)
Affinity DataIC50:  1.13E+3nMpH: 7.4 T: 2°CAssay Description:The prepared substances were tested for TAFIa inhibition using the Actichrome plasma TAFI activity kit from American Diagnostica (Pr. No. 874). This ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCarboxypeptidase B(Homo sapiens (Human))
Sanofi-Aventis Deutschland

US Patent
LigandPNGBDBM120794(US8710232, 28)
Affinity DataIC50:  1.44E+3nMpH: 7.4 T: 2°CAssay Description:The prepared substances were tested for TAFIa inhibition using the Actichrome plasma TAFI activity kit from American Diagnostica (Pr. No. 874). This ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCarboxypeptidase B(Homo sapiens (Human))
Sanofi-Aventis Deutschland

US Patent
LigandPNGBDBM120792(US8710232, 25)
Affinity DataIC50:  1.05E+4nMpH: 7.4 T: 2°CAssay Description:The prepared substances were tested for TAFIa inhibition using the Actichrome plasma TAFI activity kit from American Diagnostica (Pr. No. 874). This ...More data for this Ligand-Target Pair
In DepthDetails US Patent